RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+19.74%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.6B
AUM Growth
+$1.6B
(+18%)
Cap. Flow
+$96.8M
Cap. Flow
% of AUM
6.07%
Top 10 Holdings %
Top 10 Hldgs %
27.52%
Holding
150
New
14
Increased
55
Reduced
11
Closed
12
Top Buys
| 1 |
Merck
MRK
|
$36.7M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$15.8M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$14.7M |
| 4 |
Danaher
DHR
|
$12.5M |
| 5 |
PTHN
Patheon N.V.
PTHN
|
$11.9M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$19.8M |
| 2 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$18M |
| 3 |
Thermo Fisher Scientific
TMO
|
$14.8M |
| 4 |
Pediatrix Medical
MD
|
$9.61M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$8.41M |
Sector Composition
| 1 | Healthcare | 81.88% |
| 2 | Financials | 3.67% |
| 3 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $62.8M | 3.94% | 626,500 +146,500 | +31% | +$14.7M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $50.8M | 3.19% | 440,100 | – | – |
|
|
RDUS
3
DELISTED
Radius Health, Inc.
RDUS
| $48.2M | 3.02% | 892,000 +24,500 | +3% | +$1.33M |
|
4
Acadia Healthcare
ACHC
$2.12B
| $45.8M | 2.87% | 924,678 +87,678 | +10% | +$4.34M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $43.1M | 2.7% | 325,000 +55,000 | +20% | +$7.3M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $42.8M | 2.69% | 186,000 +4,900 | +3% | +$1.13M |
|
|
ONCE
7
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $37.5M | 2.35% | 625,000 +15,000 | +2% | +$901K |
|
|
8
Merck
MRK
$210B
| $36.7M | 2.3% | +587,500 | New | +$36.7M |
|
9
Pfizer
PFE
$141B
| $35.8M | 2.24% | 1,055,800 | – | – |
|
|
AAAP
10
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $35.4M | 2.22% | 930,000 +9,000 | +1% | +$343K |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $32.7M | 2.05% | 267,250 +31,750 | +13% | +$3.89M |
|
12
Intuitive Surgical
ISRG
$170B
| $32.6M | 2.04% | 45,000 +1,000 | +2% | +$725K |
|
13
HCA Healthcare
HCA
$94.5B
| $32.5M | 2.04% | 430,000 | – | – |
|
14
Cigna
CI
$80.3B
| $29.8M | 1.87% | 228,500 +21,700 | +10% | +$2.83M |
|
15
Collegium Pharmaceutical
COLL
$1.22B
| $29.8M | 1.87% | 1,545,000 +330,000 | +27% | +$6.36M |
|
|
WCG
16
DELISTED
Wellcare Health Plans, Inc.
WCG
| $27.5M | 1.72% | 234,500 | – | – |
|
17
Gilead Sciences
GILD
$140B
| $27.2M | 1.71% | 344,000 +300 | +0.1% | +$23.7K |
|
|
CELG
18
DELISTED
Celgene Corp
CELG
| $26.6M | 1.67% | 254,500 | – | – |
|
19
Aclaris Therapeutics
ACRS
$209M
| $26M | 1.63% | 1,016,000 +16,000 | +2% | +$410K |
|
|
MDCO
20
DELISTED
Medicines Co
MDCO
| $25.7M | 1.61% | 681,000 +500 | +0.1% | +$18.9K |
|
|
SHPG
21
DELISTED
Shire pic
SHPG
| $25.7M | 1.61% | 132,500 +12,458 | +10% | +$2.42M |
|
22
Ardelyx
ARDX
$1.53B
| $25.6M | 1.6% | 1,975,000 +700,000 | +55% | +$9.06M |
|
23
Eli Lilly
LLY
$657B
| $22.2M | 1.39% | 276,000 | – | – |
|
24
Theravance Biopharma
TBPH
$699M
| $21.7M | 1.36% | 600,000 -100,000 | -14% | -$3.62M |
|
25
Clearside Biomedical
CLSD
$28.9M
| $21.3M | 1.33% | 1,225,000 -128,326 | -9% | -$2.23M |
|